Skip to content
thestock.space

On 6 Nov 2026, Tejnaksh Healthcare was priced at ₹12.69, or 21.1× trailing earnings, against an industry P/E of 47.7×, and the shares are 32% below their 52-week high. Its ROCE of 5.9% is the lowest among the 7 largest Medical Care Facilities peers, and sales and net profit fell 2.7% and 10.0% a year over 3 years. The company has almost no debt. It is a small-cap company with a market cap of ₹26 Cr, ranked 35th of 40 Medical Care Facilities companies by market cap; the shares fell 28% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹12.58
Day high
₹12.99
Day low
₹12.31
Prev. close
₹12.58
Volume
2K

Health check

2 good · 4 to check
  • ReturnsBehind

    −28.4% over a year, better than 0 of 7 peers.

  • Price tagCheaper

    P/E 21.1 vs industry 47.7.

  • GrowthShrinking

    Sales −2.7%, profit −10.0% a year over 3 years.

  • ProfitabilityWeak

    ROCE 5.9% vs peer median 11.9%.

  • Balance sheetSolid

    Practically debt-free, Piotroski 7 of 9.

  • Red flags2 to check

    Return on equity is low at 4.6%.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Small cap

₹26 Cr, #35 of 40 in its industry by size.

Defensive

Beta 0.55 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹11 Cr · profit ₹1 Cr
Market cap
₹26 Cr
Small cap
P/E
21.1
Industry 47.7
Price to book
0.80
Peers 8.03
Dividend yield
0.00%
ROE
4.6%
Peers 12.8%
ROCE
5.9%
Peers 11.9%
Debt to equity
0.01
Debt ₹0.25 Cr
EPS (TTM)
₹0.60
OPM (TTM)
26.5%
Net margin 11.6%
Sales growth
+0.5%
Latest quarter vs a year ago
Profit growth
+8.1%
Latest quarter vs a year ago
Price to sales
2.39
EV/EBITDA 8.4

Strengths and risks

Strengths

  • Practically debt-free.
  • P/E of 21.1 against an industry P/E of 47.7.
  • Positive operating cash flow in each of the last 4 years.

Risks to check

  • Return on equity is low at 4.6%.
  • 32% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Tejnaksh Healthcare

Tejnaksh Healthcare Limited provides hospital and healthcare services in India. The company offers health care services through urology clinics, urology hospitals, and dental super specialty clinics. It also operates multi-specialty hospitals, super-specialty hospitals, education institutes, pathology labs, super specialty training institutes, simulation institutes, and stone analysis labs, as well as sells healthcare equipment, medical goods, and…

Headquarters
Dhule
Employees
34
Sector
Healthcare
ISIN
INE030T01027
Website
tejnaksh.com

Price range

52 weeks

₹10.65₹18.60

Today

₹12.31₹12.99
Avg volume (3M)
7.4K
1-year return
minus 28.4%
From 52-week high
minus 31.8%

Peers · Medical Care Facilities

Compare with peersScreen the whole industry
Company
APOLLOHOSPApollo Hospitals Enterprise8,446.00plus 0.90%1,21,44154.011.4519.2%22.5%15.1%14.8%33.3%0.24%plus 7.2%
MAXHEALTHMax Healthcare Institute934.00plus 0.21%90,90966.18.0312.6%12.8%26.8%22.4%9.3%0.21%minus 18.1%
MANIPALHOSManipal Health Enterprises646.70minus 1.61%85,065133.69.059.8%9.2%17.8%––0.00%minus 1.5%
ASTERDMAster DM Quality Care713.15minus 0.89%62,092115.68.039.4%9.7%19.2%15.7%−3.0%0.42%plus 4.5%
FORTISFortis Healthcare766.90minus 6.45%57,89855.35.5211.9%11.1%22.4%13.3%20.9%0.12%minus 19.6%
NHNarayana Hrudayalaya1,903.00minus 0.65%38,65044.77.7311.4%19.1%18.5%20.5%9.9%0.23%plus 4.7%
MEDANTAGlobal Health1,387.60minus 0.15%37,26460.48.6315.0%15.2%20.9%17.2%19.5%0.04%plus 11.2%
TEJNAKSHTejnaksh Healthcare12.69plus 0.87%2621.10.805.9%4.6%26.5%−2.7%−10.0%0.00%minus 28.4%
Median of 7 peers–−0.65%62,09260.48.0311.9%12.8%19.2%16.5%14.7%0.21%4.5%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
2.632.62.62.7
22.21.91.82
0.60.80.70.70.7
22.8%26.0%26.3%27.9%26.0%
0.10.10.10.20.1
0.100–0
0.40.30.40.40.4
0.30.50.40.50.4
25.4%31.7%19.2%32.9%38.0%
0.30.30.30.40.3
0.120.150.150.170.13

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
−2.7%
Profit CAGR 3Y
−10.0%
EPS CAGR 3Y
−9.8%
ROE
4.6%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
11.511.912.710.6
–+3.8%+6.4%minus 16.7%
7.77.78.67.7
3.84.24.12.9
32.8%35.1%32.6%27.6%
0.30.30.40.3
0.60.60.40.1
0.90.90.91.4
−0.1−0.5−0−0.1
2.52.43.21.6
28.7%25.7%30.1%28.3%
1.71.82.31.2
–+5.5%+31.1%minus 47.2%
0.830.871.150.61

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
10.210.210.210.2
11.613.415.817
6.44.81.10.2
333.32.7
31.231.430.330.1
2019.71918.5
0–––
0.50.51.40.1
3.14.31.82
7.66.98.19.4
31.231.430.330.1

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
2.140.21.7
−1.4−13.7−0.3
−1.2−2.3−3.9−1.2
−0.50.700.2
−0.9−0.8−0.5−0.5
1.23.2−0.31.2

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you